EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of H pylori infection increases clarithromycin resistance in the normal microflora



Treatment of H pylori infection increases clarithromycin resistance in the normal microflora



Gut 45(SUPPL 3): A5-A6, Sept




(PDF 0-2 workdays service: $29.90)

Accession: 035980427

Download citation: RISBibTeXText



Related references

Treatment of Helicobacter pylori infection causes persistent macrolide resistance in the normal microflora. IJMM International Journal of Medical Microbiology 291(Supplement 31): 11, September, 2001

Prevalence of resistance of H pylori resistance to clarithromycin and metronidazole following treatment failure and genetic basis of resistance to clarithromycin. Gut 41(SUPPL 1): A10, 1997

Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin. Helicobacter 2(4): 185-187, 1998

Prevalence of resistance of Helicobacter pylori to clarithromycin and metronidazole following treatment failure and genetic basis of resistance to clarithromycin. Gastroenterology 112(4 SUPPL ): A1088, 1997

Clarithromycin resistance and efficacy of clarithromycin-containing triple eradication therapy for Helicobacter pylori infection in type 2 diabetes mellitus patients. Southern Medical Journal 102(11): 1116-1120, 2009

A six-year surveillance of H pylori resistance in a large study population in the Netherlands Prevalence of clarithromycin resistance increases, while metronidazole resistance does not increase. Gastroenterology 120(5 Supplement 1): A 229, April, 2001

Clarithromycin for first-line treatment of Helicobacter pylori infection after culture in high-resistance regions. European Journal of Gastroenterology & Hepatology 26(12): 1380-1384, 2015

Clarithromycin resistance, but not CYP2C-19 polymorphism, has a major impact on treatment success in a 7-day treatment regimen for cure of H pylori infection A logistic regression analysis. Gastroenterology 118(4 Suppl 2 Part 1): AGA A498-AGA A499, April, 2000

Clarithromycin resistance, but not CYP2C-19 polymorphism, has a major impact on treatment success in 7-day treatment regimen for cure of H. pylori infection: A multiple logistic regression analysis. Digestive Diseases & Sciences 46(11): 2445-2450, November, 2001

Helicobacter pylori resistance to clarithromycin increases with the age of patients. Gut 47(Supplement 1): A7-A8, October, 2000

The importance of clarithromycin dose in the treatment of H pylori infection A meta-analysis of comparative studies with a proton pump inhibitor , amoxicillin and clarithromycin. Gastroenterology. 116(4 Part 2): A65, Il, 1999

Clinical role and importance of fluorescence in situ hybridization method in diagnosis of H pylori infection and determination of clarithromycin resistance in H pylori eradication therapy. World Journal of Gastroenterology 13(5): 671-675, 2007

H pylori resistance to metronidazole and clarithromycin Which role for age, gender, secondary resistance and resistance stability of clarithromycin?. Ijmm International Journal Of Medical Microbiology. 291(supplement 31): 18, Ember, 2001

Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan. European Journal of Gastroenterology & Hepatology 15(1): 27-33, 2003